CURRENT STATUS OF THERAPY FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

被引:3
|
作者
LANE, HC
机构
[1] National Institutes of Health, Bethesda, MD
关键词
D O I
10.1016/S0952-7915(06)80044-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The past year has seen refinement in our ability to delay the progression of human immunodeficiency virus type 1 infection through the use of nucleoside analogues, singly or in combination. Progress has also been made in our ability to detect drug-resistant isolates of human immunodeficiency virus type 1 and to begin to put the laboratory observations of resistance into a clinical context.
引用
收藏
页码:486 / 489
页数:4
相关论文
共 50 条
  • [1] MORPHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CHATTERJEE, S
    BASAK, S
    KHAN, NC
    PATHOBIOLOGY, 1992, 60 (04) : 181 - 186
  • [2] RADIOSENSITIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CONWAY, B
    TOMFORD, WW
    CLINICAL INFECTIOUS DISEASES, 1992, 14 (04) : 978 - 979
  • [3] VARIANTS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    TOURNIER, JN
    VERRIER, B
    BIRON, FF
    MANDRAND, B
    PEYRAMOND, D
    MEDECINE ET MALADIES INFECTIEUSES, 1995, 25 (05): : 709 - 715
  • [4] INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    PEDERSEN, C
    DANISH MEDICAL BULLETIN, 1994, 41 (01) : 12 - 22
  • [5] COMBINATION THERAPY FOR INFECTION DUE TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CALIENDO, AM
    HIRSCH, MS
    CLINICAL INFECTIOUS DISEASES, 1994, 18 (04) : 516 - 524
  • [6] POSTEXPOSURE CHEMOPROPHYLAXIS FOR OCCUPATIONAL EXPOSURE TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 - CURRENT STATUS AND PROSPECTS FOR THE FUTURE
    HENDERSON, DK
    AMERICAN JOURNAL OF MEDICINE, 1991, 91 : S312 - S319
  • [7] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION OF THE BRAIN
    ATWOOD, WJ
    BERGER, JR
    KADERMAN, R
    TORNATORE, CS
    MAJOR, EO
    CLINICAL MICROBIOLOGY REVIEWS, 1993, 6 (04) : 339 - 366
  • [8] TRANSMISSION AND PATHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CONNOR, RI
    HO, DD
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (04) : 321 - 323
  • [9] CELLULAR LATENCY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    POMERANTZ, RJ
    BAGASRA, O
    BALTIMORE, D
    CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (04) : 475 - 480
  • [10] INACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY ALCOHOLS
    VANBUEREN, J
    LARKIN, DP
    SIMPSON, RA
    JOURNAL OF HOSPITAL INFECTION, 1994, 28 (02) : 137 - 148